The pharmaceutical industry is under immense threat and pressure to replenish their pipelines. Like many industries, pharmaceuticals need to have an open innovation business model, but those who have adopted OI are beginning to struggle as their partnerships enter new phases. As relationships mature, pharmaceuticals must be able to track and strategically manage partnerships to ensure sustainability and profitability. Most importantly, all partners need to ensure these collaboration projects are in-line with their corporate objectives.
This marcus evans forum delves into alliance management within an open innovation space and updates delegates with the current technological advances, IP and funding opportunities. It will be the perfect opportunity for delegates to learn from case studies how to minimise risks, time and cost expenditure. This event will take place June 27-28 in Munich.